Evidence map›Paper›PMID 25182519›Full record

ArticleHuman genetics2014

Whole exome sequence analysis of Peters anomaly.

Eric Weh, Linda M Reis, Hannah C Happ, Alex V Levin, Patricia G Wheeler, Karen L David, Erin Carney, Brad Angle, Natalie Hauser, Elena V Semina

Open access · greenAbstract read
In one paragraph

Article in Human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Genetic Aspects of Glaucoma: An Updated Review.Current molecular medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Early Embryonic Expression ofJournal of cardiovascular development and disease · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Eric WehDepartment of Pediatrics and Children's Research Institute, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Linda M Reis
Hannah C Happ
Alex V Levin
Patricia G Wheeler
Karen L David
Erin Carney
Brad Angle
Natalie Hauser
Elena V Semina
Medical College of Wisconsin · USNewYork–Presbyterian Brooklyn Methodist Hospital · USLurie Children's Hospital · USNemours Children's Clinic · USSouthwestern Medical CenterWills Eye Hospital · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR031973 · NCRR · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2010 to 2011
$7.9M
Molecular Mechanisms of Axenfeld-Rieger SyndromeR01EY015518 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2005 to 2026
$5.6M
Rresearch Training Program in Vision ScienceT32EY014537 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2002 to 2026
$4.2M
NCRR NIH HHS 1UL1RR031973NCRR NIH HHS UL1 RR031973NEI NIH HHS R01 EY015518NEI NIH HHS R01EY015518NEI NIH HHS T32 EY014537
6 · The paper itself

Abstract

Peters anomaly is a rare form of anterior segment ocular dysgenesis, which can also be associated with additional systemic defects. At this time, the majority of cases of Peters anomaly lack a genetic diagnosis. We performed whole exome sequencing of 27 patients with syndromic or isolated Peters anomaly to search for pathogenic mutations in currently known ocular genes. Among the eight previously recognized Peters anomaly genes, we identified a de novo missense mutation in PAX6, c.155G>A, p.(Cys52Tyr), in one patient. Analysis of 691 additional genes currently associated with a different ocular phenotype identified a heterozygous splicing mutation c.1025+2T>A in TFAP2A, a de novo heterozygous nonsense mutation c.715C>T, p.(Gln239*) in HCCS, a hemizygous mutation c.385G>A, p.(Glu129Lys) in NDP, a hemizygous mutation c.3446C>T, p.(Pro1149Leu) in FLNA, and compound heterozygous mutations c.1422T>A, p.(Tyr474*) and c.2544G>A, p.(Met848Ile) in SLC4A11; all mutations, except for the FLNA and SLC4A11 c.2544G>A alleles, are novel. This is the first study to use whole exome sequencing to discern the genetic etiology of a large cohort of patients with syndromic or isolated Peters anomaly. We report five new genes associated with this condition and suggest screening of TFAP2A and FLNA in patients with Peters anomaly and relevant syndromic features and HCCS, NDP and SLC4A11 in patients with isolated Peters anomaly.

Indexed as

ExomeAmino Acid SequenceAnion Transport ProteinsAnterior Eye SegmentAntiportersChildCorneal OpacityDNA Mutational AnalysisEye AbnormalitiesEye ProteinsFilaminsGenetic Association StudiesGenetic Predisposition to DiseaseHomeodomain ProteinsHumansInfantAnion Transport ProteinsAntiporterscytochrome C synthetaseEye ProteinsFilaminsFLNA protein, humanHomeodomain ProteinsLyasesNDP protein, humanNerve Tissue ProteinsPaired Box Transcription FactorsPAX6 protein, humanPAX6 Transcription FactorRepressor ProteinsSLC4A11 protein, humanTFAP2A protein, humanTranscription Factor AP-2

Identifiers

PMID25182519
PMCPMC4395516
OpenAlexW2020570800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.